|
Home : Unsafe Drugs : Avandia : Newsfeeds : Heart risks of diabetes drugs compared Heart risks of diabetes drugs compared
Pioglitazone remains licensed for use in type 2 diabetes, provided that patients meet certain eligibility criteria and that any adverse effects of the drug are monitored. This study was authored by researchers from the University of East Anglia and Johns ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




